PParis Read More Delta Expands its Austin Network With New Paris ServiceAugust 18, 2026 Delta Air Lines DAL is strengthening its presence in Austin by launching its first-ever nonstop service between Austin-Bergstrom International…
AAirbus Read More Is Airbus Strengthening Its Position in Military Helicopters?August 17, 2026 Airbus SEEADSY is strengthening its position in the global military helicopter market through its Airbus Helicopters business. Rising…
SStellantis Read More Stellantis Planning To Sell Ontario Auto Plant: ReportsAugust 17, 2026 Media reports say that automaker Stellantis (STLA) is planning to close and sell its idle vehicle manufacturing plant…
CCarrefour Read More GXO renews long-term partnership with Carrefour in BelgiumJuly 23, 2026 ZELLIK, Belgium, June 24, 2026 (GLOBE NEWSWIRE) — GXO Logistics, Inc. (NYSE: GXO), the world’s largest pureplay contract logistics provider, today announced the renewal…
AAirbus Read More Airbus to Deliver 18 A330-900 Aircraft to Scandinavian AirlinesJuly 3, 2026 Airbus SEEADSY recently secured a firm order from Scandinavian Airlines (“SAS”) to deliver 18 of its A330-900 widebody…
SSanofi Read More Bargain Hunters: These 3 High-Yielding Stocks Recently Hit New 52-Week LowsJune 30, 2026 Key Points When dividend stocks drop in value, investors have the opportunity to secure some higher-than-typical yields. The…
AAirbus Read More Boeing vs. Airbus: Which Aerospace Giant Is the Better Investment Now?June 23, 2026 The Boeing CompanyBA and Airbus SEEADSY are the two dominant players in the global aerospace industry. Together, they…
AAirbus Read More Boeing vs. Airbus: Which Aerospace Giant Is the Better Investment Now?June 22, 2026 The Boeing CompanyBA and Airbus SEEADSY are the two dominant players in the global aerospace industry. Together, they…
SStellantis Read More Ford vs. Stellantis: Which Auto Manufacturer Is a Better Choice?June 22, 2026 Both the leading automakers, Ford Motor CompanyF and Stellantis N.V. STLA, have recently announced strategic partnerships to strengthen…
SSanofi Read More Can Sanofi Rely on Dupixent to Drive Long-Term Revenue Growth?June 22, 2026 Sanofi’s SNY Dupixent, which it co-develops with Regeneron REGN, is its key top-line driver. The drug has transformed the treatment…
SSanofi Read More Sanofi Wins EU Nod for Subcutaneous Sarclisa in Multiple MyelomaJune 8, 2026 Sanofi SNY announced that the European Commission (EC) has approved the subcutaneous (under the skin or SC) formulation…
SSanofi Read More Sanofi Wins EU Nod for Subcutaneous Sarclisa in Multiple MyelomaJune 8, 2026 Sanofi SNY announced that the European Commission (EC) has approved the subcutaneous (under the skin or SC) formulation…